山东大学教师主页刘新泳 Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1 中文主页

Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1: 发布时间：2019-10-03 | 点击次数：

所属单位：药学院

发表刊物：Expert Opinion on Therapeutic Patents

第一作者：程锡强

全部作者：展鹏,刘新泳

论文类型：基础研究

论文编号：A9472303DA3F4813AA4416BF776CD379

卷号： 27

期号：11

页面范围：1277

是否译文：否

发表时间：2017-06

上一条： Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)

下一条： Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization